1.
Bioorg Med Chem Lett
; 16(24): 6293-7, 2006 Dec 15.
Artículo
en Inglés
| MEDLINE
| ID: mdl-17005393
RESUMEN
Novel tetrahydroisoquinolines have been developed as potent PPAR ligands. Evaluation of these compounds in PPARgamma responsive models of type 2 diabetes is described.